Cite
MLA Citation
Majid Assadi et al.. “Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers.” Clinical nuclear medicine, vol. 46, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100174361083.0x000015